InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,040.04
(
1.10%
)
US TECH 100
21,198.40
(
1.36%
)
Dow Jones
43,297.03
(
0.91%
)
Brent Oil
73.29
(
0.00%
)
Bitcoin
98,290.90
(
-0.39%
)
Post# of 254002
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120928
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 192918

Monday, 07/20/2015 11:33:57 AM

Monday, July 20, 2015 11:33:57 AM

Post# of 254002
EXAS’ 2Q15 results are in-line with guidance given on 6/25/15 Investor Day (#msg-114911581):

http://finance.yahoo.com/news/exact-sciences-highlights-cologuard-positive-090200489.html

Exact Sciences today announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter, up more than 90 percent from the first quarter, which resulted in $8.1 million in revenue. Additionally, the cumulative number of ordering physicians grew to 14,700 during the quarter, a 77 percent increase.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up